Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS) Meeting Abstract
| Authors: | Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; Khokhar, N. Z.; Maki, R. G.; Patel, S.; Cleeland, C. S. |
| Abstract Title: | Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 584s |
| Language: | English |
| ACCESSION: | WOS:000404712500453 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.11061 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11061 -- Source: Wos |
